What Researchers Did
The authors searched the medical literature for clinical trials of treatments for dry mouth caused by low saliva production and sorted the treatments by how strong the evidence was.
What They Found
This literature review of 25 clinical trials found that pilocarpine and cevimeline had the strongest evidence of benefit for low saliva production, while hyperbaric oxygen had no supporting evidence for this condition. In most of the studies, the number of participants was low and the follow-up times were short. Citric and malic acids increased saliva flow but also raised the risk of tooth erosion and cavities. No controlled clinical trials supported acupuncture, stem cell therapy or gene therapy, although clinical observations suggested a promising effect. The abstract also found no evidence supporting salivary substitutes, chewing gum or bethanechol.
What This Means for Canadian Patients
For people with dry mouth from low saliva production, this review reports that the best evidence among the treatments it examined was for pilocarpine and cevimeline. It states that there is no evidence supporting hyperbaric oxygen for treating this condition. The abstract does not describe any hyperbaric oxygen protocol, pressure or number of sessions.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract reports that most of the included studies had few participants and short follow-up times, and it describes the review as a search of one database, MEDLINE/PubMed.